Treatment of heart failure with normal ejection fraction

Current Treatment Options in Cardiovascular Medicine

Volumn 13, Issue 1, 2011, Pages 26-34

  Hamdani, Nazha ^a   Paulus, Walter J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIGOXIN; DIURETIC AGENT; IRBESARTAN; NEBIVOLOL; PERINDOPRIL; PLACEBO; SILDENAFIL; SPIRONOLACTONE;

ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG MECHANISM; DRUG RESPONSE; HEART FAILURE; HEART FAILURE WITH NORMAL EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE REPLACEMENT; HUMAN; HYPERKALEMIA; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; KIDNEY FAILURE; LIFESTYLE MODIFICATION; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 79551627796     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0103-8     Document Type: Article

References (40)

1. F Bursi SA Weston MM Redfield, et al. 2006 Systolic and diastolic heart failure in the community JAMA 296 2209 2216 1:CAS:528:DC%2BD28XhtFKrtb%2FI 10.1001/jama.296.18.2209 17090767 (Pubitemid 44708051)
2. S Brucks WC Little T Chao, et al. 2005 Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction Am J Cardiol 95 603 606 10.1016/j.amjcard.2004.11.006 15721099 (Pubitemid 40255248)
3. DW Kitzman WC Little PH Brubaker, et al. 2002 Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA 288 2144 2150 10.1001/jama.288.17.2144 12413374 (Pubitemid 35265382)
4. MR Zile WH Gaasch JD Carroll, et al. 2001 Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104 779 782 1:STN:280:DC%2BD3Mvls12hug%3D%3D 10.1161/hc3201.094226 11502702
5. WJ Paulus C Tschope JE Sanderson, et al. 2007 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2539 2550 10.1093/eurheartj/ehm037 17428822 (Pubitemid 47614269)
6. K Dickstein A Cohen-Solal G Filippatos, et al. 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 933 989 10.1016/j.ejheart. 2008.08.005 18826876 This article updates strategies for the diagnosis and treatment of HF patients
7. SA Hunt DW Baker MH Chin, et al. 2001 ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America Circulation 104 2996 3007 1:STN:280:DC%2BD3MnptFejug%3D%3D 10.1161/hc4901.102568 11739319
8. SA Hunt DW Baker MH Chin, et al. 2001 ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2101 2113 1:STN:280:DC%2BD3MnptVegtg%3D%3D 10.1016/S0735-1097(01)01683-7 11738322 (Pubitemid 33116591)
9. BM Massie PE Carson JJ McMurray, et al. 2008 Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2456 2467 1:CAS:528:DC%2BD1cXhsVCrurjE 10.1056/NEJMoa0805450 19001508 This article reports on the largest outcome trial performed in HFNEF
10. JG Cleland M Tendera J Adamus, et al. 2006 The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2338 2345 1:CAS:528:DC%2BD28Xht1Sgu7zN 10.1093/eurheartj/ehl250 16963472 (Pubitemid 44453578)
11. S Yusuf MA Pfeffer K Swedberg, et al. 2003 Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 777 781 1:CAS:528: DC%2BD3sXntVGktLg%3D 10.1016/S0140-6736(03)14285-7 13678871 (Pubitemid 37093918)
12. A Ahmed MW Rich JL Fleg, et al. 2006 Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation 114 397 403 1:CAS:528:DC%2BD28Xnt1agsbo%3D 10.1161/CIRCULATIONAHA.106.628347 16864724 (Pubitemid 44264821)
13. R Garg S Yusuf 1995 Overview of randomized trials of angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1450 1456 1:STN:280:DyaK2M3jvFyrtw%3D%3D 10.1001/jama.273.18.1450 7654275
14. A Hjalmarson S Goldstein B Fagerberg, et al. 2000 Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF) MERIT-HF Study Group JAMA 283 1295 1302 1:CAS:528:DC%2BD3cXitVCktbk%3D 10.1001/jama.283.10.1295 10714728
15. JN Cohn G Tognoni 2001 A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 1667 1675 1:CAS:528:DC%2BD3MXovFKjtLc%3D 10.1056/NEJMoa010713 11759645 (Pubitemid 33126822)
16. MR Zile DL Brutsaert 2002 New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment Circulation 105 1503 1508 10.1161/hc1202.105290 11914262 (Pubitemid 34263285)
17. N Angomachalelis AI Hourzamanis S Sideri, et al. 1996 Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection Heart Vessels 11 303 309 1:STN:280:DyaK2szpt1WitA%3D%3D 10.1007/BF01747189 9248849 (Pubitemid 27298205)
18. K Mitsunami S Inoue K Maeda, et al. 1998 Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension Cardiovasc Drugs Ther 12 469 474 1:CAS:528:DyaK1MXht1Cqtrs%3D 10.1023/A:1007754100351 9926278 (Pubitemid 29002785)
19. EF Philbin TA Rocco Jr NW Lindenmuth, et al. 2000 Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors Am J Med 109 605 613 1:CAS:528:DC%2BD3cXotlGjt7c%3D 10.1016/S0002-9343(00)00601-X 11099679
20. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325:293-302.
21. MD Flather MC Shibata AJ Coats, et al. 2005 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 215 225 1:CAS:528:DC%2BD2MXksFCgtbc%3D 10.1093/eurheartj/ehi115 15642700 (Pubitemid 40222359)
22. M Packer MB Fowler EB Roecker, et al. 2002 Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2194 2199 10.1161/01.CIR.0000035653.72855.BF 12390947 (Pubitemid 35222212)
23. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
24. Effect of metoprolol CR/XL in chronic heart failure 1999 Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 2001 2007 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
25. MJ Domanski H Krause-Steinrauf BM Massie, et al. 2003 A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS J Card Fail 9 354 363 1:CAS:528:DC%2BD3sXpsleqtrY%3D 10.1054/S1071-9164(03)00133-7 14583895 (Pubitemid 37351802)
26. WJ Paulus JJ van Ballegoij 2010 Treatment of heart failure with normal ejection fraction: an inconvenient truth J Am Coll Cardiol 55 526 537 10.1016/j.jacc.2009.06.067 20152557
27. L van Heerebeek A Borbely HW Niessen, et al. 2006 Myocardial structure and function differ in systolic and diastolic heart failure Circulation 113 1966 1973 10.1161/CIRCULATIONAHA.105.587519 16618817
28. MR Zile CF Baicu WH Gaasch 2004 Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle N Engl J Med 350 1953 1959 1:CAS:528:DC%2BD2cXjslehs7o%3D 10.1056/NEJMoa032566 15128895 (Pubitemid 38580198)
29. N Hamdani WJ Paulus L van Heerebeek, et al. 2009 Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction Eur Heart J 30 1863 1872 1:CAS:528: DC%2BD1MXpsVars7s%3D 10.1093/eurheartj/ehp189 19487234
30. A Desai JC Fang 2008 Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy Heart Fail Clin 4 87 97 10.1016/j.hfc.2007.11.001 18313627 (Pubitemid 351291707)
31. D Susic ED Frohlich 2008 Optimal treatment of hypertension with diastolic heart failure Heart Fail Clin 4 117 124 10.1016/j.hfc.2007.10.002 18313629 (Pubitemid 351289327)
32. N Suskin T Sheth A Negassa, et al. 2001 Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction J Am Coll Cardiol 37 1677 1682 1:STN:280:DC%2BD3M3ktFSlsQ%3D%3D 10.1016/S0735-1097(01)01195-0 11345383 (Pubitemid 32386007)
33. WH Gaasch MR Zile 2004 Left ventricular diastolic dysfunction and diastolic heart failure Annu Rev Med 55 373 394 1:CAS:528:DC%2BD2cXitVWrurk%3D 10.1146/annurev.med.55.091902.104417 14746527 (Pubitemid 38316733)
34. CG Brilla RC Funck H Rupp 2000 Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease Circulation 102 1388 1393 1:CAS:528:DC%2BD3cXntFKksbY%3D 10993857
35. SA Hunt WT Abraham MH Chin, et al. 2005 ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society Circulation 112 e154 e235 10.1161/CIRCULATIONAHA.105.167586 16160202
36. RO Bonow MB Leon DR Rosing, et al. 1982 Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise Circulation 65 1337 1350 1:STN:280:DyaL387osVKruw%3D%3D 7074794
37. GW Yip M Wang T Wang, et al. 2008 The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction Heart 94 573 580 1:STN:280:DC%2BD1c3kvVKjsg%3D%3D 10.1136/hrt.2007.117978 18208835 (Pubitemid 351580128)
38. G Shanmugam JF Legare 2008 Revascularization for ischaemic cardiomyopathy Curr Opin Cardiol 23 148 152 10.1097/HCO.0b013e3282f43011 18303528 (Pubitemid 351321583)
39. WS Weintraub WE Boden Z Zhang, et al. 2008 Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients Circ Cardiovasc Qual Outcomes 1 12 20 10.1161/CIRCOUTCOMES.108.798462 20031783
40. A Vahanian H Baumgartner J Bax, et al. 2007 Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 230 268 17259184